Analystreport

Acasti Pharma Inc (NASDAQ: ACST) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

Acasti Pharma, Inc.  (ACST) 
Last acasti pharma, inc. earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors